These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12725955)

  • 1. The interaction between platelets and factor VII/VIIa.
    Lau HK
    Transfus Apher Sci; 2003 Jun; 28(3):279-83. PubMed ID: 12725955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VII and haemostasis.
    Osterud B
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
    Hoffman M; Monroe DM; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S61-5. PubMed ID: 9819030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilic synovitis: factor VII and the potential role of extravascular factor VIIa.
    Monahan PE; Sun J
    Thromb Res; 2010 Apr; 125 Suppl 1():S63-6. PubMed ID: 20227556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution to the mechanism of the "factor VIII bypassing activity" (FEIBA)-reaction].
    Sander W; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):581-7. PubMed ID: 1714863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII.
    Chin C
    Paediatr Anaesth; 2006 Sep; 16(9):907-9. PubMed ID: 16918650
    [No Abstract]   [Full Text] [Related]  

  • 8. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the initiation of coagulation by RNA aptamers to factor VIIa.
    Rusconi CP; Yeh A; Lyerly HK; Lawson JH; Sullenger BA
    Thromb Haemost; 2000 Nov; 84(5):841-8. PubMed ID: 11127866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa.
    Aitken MG
    Emerg Med Australas; 2004; 16(5-6):446-55. PubMed ID: 15537408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation cascade.
    Green D
    Hemodial Int; 2006 Oct; 10 Suppl 2():S2-4. PubMed ID: 17022746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients.
    Meng ZH; Wolberg AS; Monroe DM; Hoffman M
    J Trauma; 2003 Nov; 55(5):886-91. PubMed ID: 14608161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
    van 't Veer C; Golden NJ; Mann KG
    Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor VII. (Biochemistry, role in blood coagulation, methods of assay, congenital deficiencies and relationship with thrombosis).
    Mariani G; Mandelli F
    Ric Clin Lab; 1983; 13(3):287-98. PubMed ID: 6606207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
    van't Veer C; Mann KG
    Semin Thromb Hemost; 2000; 26(4):367-72. PubMed ID: 11092210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
    Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
    Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.